IP Library Granted Patent US 9,901,687
Granted Patent B2
US 9,901,687 · App. 13/868,649 · Granted Feb 27, 2018

Implantable drug-delivery devices, and apparatus and methods for refilling the devices

Inventors: Ellis Fan-chuin Meng (Alhambra, CA); Mark S. Humayun (Glendale, CA); Ronalee Lo Mann (Menlo Park, CA); Po-Ying Li (Monrovia, CA); Saloomeh Saati (Placentia, CA)
Assignee: UNIVERSITY OF SOUTHERN CALIFORNIA
A61M5/427A61F9/0017A61M5/14276A61M5/158A61M5/46A61M39/0208A61M2005/14284A61M2039/0238A61M2205/3523A61M2205/581A61M2205/582A61M2205/583A61M2205/6054A61M2205/6063A61M2209/045A61M2210/0612
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,901,687
App. No.
13/868,649
Granted
Feb 27, 2018
Kind
B2
Abstract

In various embodiments, a needle is employed in refilling drug-delivery devices.

Claims (22)

1. An implantable drug-delivery device, comprising:

a drug reservoir;

a needle entry port comprising a throat for receiving a refill needle therethrough, the throat opening into a vestibule that is in fluid communication with the drug reservoir; and

a visualization ring surrounding the needle entry port, the visualization ring being visible through ocular tissue so as to visually indicate a position of the needle entry port,

wherein the vestibule (i) is wider than the throat, and (ii) comprises a stop on a wall opposite the throat for halting progress of a needle into the vestibule through the throat.

2. The implantable drug-delivery device of claim 1 , wherein the stop is sized so as to halt the progress of a needle comprising an exit port at a point at which the exit port is in fluid communication with the vestibule.

3. The implantable drug-delivery device of claim 1 , wherein a top surface of the stop is cupshaped.

4. The implantable drug-delivery device of claim 1 , wherein the stop is constructed of a biocompatible material.

5. The implantable drug-delivery device of claim 1 , wherein the stop is constructed of at least one of a metal, a plastic, or a composite material.

6. The implantable drug-delivery device of claim 1 , wherein the stop is constructed of a material selected from the group consisting of PDMS, polyimide, polypropylene, PEEK, polycarbonate, an acetyl film, polyoxymethylene plastic, gold, stainless steel, nickel, and chrome.

7. The implantable drug-delivery device of claim 1 further comprising a check valve located between the vestibule and the drug reservoir.

8. The implantable drug-delivery device of claim 1 , wherein the needle entry port further comprises a self-sealing material.

9. The implantable drug-delivery device of claim 1 , wherein the visualization ring is constructed of a biocompatible material.

10. The implantable drug-delivery device of claim 1 , wherein the visualization ring is constructed of a material that withstands penetration by the refill needle.

11. The implantable drug-delivery device of claim 1 , wherein the visualization ring is visible through a patient's conjunctiva.

12. The implantable drug-delivery device of claim 1 , wherein the visualization ring comprises a light emitting diode.

13. The implantable drug-delivery device of claim 1 further comprising a light emitting diode and optical fiber for conducting light from the light emitting diode to and around the visualization ring.

14. The implantable drug-delivery device of claim 1 , wherein the visualization ring comprises a material that enhances surface echogenicity and acoustic shadowing.

15. The implantable drug-delivery device of claim 1 further comprising electronics to move or vibrate the visualization ring.

16. The implantable drug-delivery device of claim 1 , wherein the visualization ring comprises a magnetic material.

17. The implantable drug-delivery device of claim 1 , wherein the visualization ring comprises a fluorescent pigment.

18. The implantable drug-delivery device of claim 17 , wherein the fluorescent pigment is selected from the group consisting of a luminescent aerogel, a nanoparticle, a phthalocyanine pigment, fluorescein isothiocyanate, rhodamine, coumarin, cyanine, an Alexa Fluor, a DyLight Fluor, a quantum dot, a green fluorescent protein, and a luciferin.

Assignments (2)
CONFIRMATORY LICENSE Recorded Jun 22, 2024
From: UNIVERSITY OF SOUTHERN CALIFORNIA
To: NATIONAL SCIENCE FOUNDATION
Reel/Frame 067808/0211 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 2, 2013
From: MENG, ELLIS; HUMAYUN, MARK; LO, RONALEE; LI, PO-YING; SAATI, SALOOMEH
To: UNIVERSITY OF SOUTHERN CALIFORNIA
Reel/Frame 030333/0010 →
Continuity (3)
Division 12348178 · Jan 2, 2009
Provisional Application 61018747 · Jan 3, 2008
Related Publication 20130289482A1 · Oct 31, 2013